Clinicopathological features and the prognosis of IgA nephropathy in Japanese children on long-term observation

2005 ◽  
Vol 64 (09) ◽  
pp. 171-179 ◽  
Author(s):  
R. Nozawa ◽  
J. Suzuki ◽  
A. Takahashi ◽  
M. Isome ◽  
Y. Kawasaki ◽  
...  
1990 ◽  
Vol 10 (3) ◽  
pp. 191-197 ◽  
Author(s):  
Kaname Okada ◽  
Mamoru Funai ◽  
Koichiro Kawakami ◽  
Shoji Kagami ◽  
Ichiro Yano ◽  
...  

2017 ◽  
Vol 32 (suppl_3) ◽  
pp. iii58-iii59
Author(s):  
Ryouya Tsunoda ◽  
Joichi Usui ◽  
Junichi Hoshino ◽  
Takayuki Fujii ◽  
Satoshi Suzuki ◽  
...  

2009 ◽  
Vol 26 (2) ◽  
pp. 83-88 ◽  
Author(s):  
Hirohito Yano ◽  
Naoyuki Ohe ◽  
Noriyuki Nakayama ◽  
Jun Shinoda ◽  
Toru Iwama

2001 ◽  
Author(s):  
L Szczepanski ◽  
C Stepniak ◽  
B Targonska-Stepniak

BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Yutaka Okagawa ◽  
Tetsuya Sumiyoshi ◽  
Hitoshi Kondo ◽  
Yusuke Tomita ◽  
Takeshi Uozumi ◽  
...  

Abstract Background Recent studies have shown that mixed predominantly differentiated-type (MD) early gastric cancer (EGC) might have more malignant potential than pure differentiated-type (PD) EGC. However, no study has analyzed all differentiated-type EGC cases treated endoscopically and surgically. This study aimed to compare the differences in clinicopathological features and long-term prognosis between MD- and PD-EGC. Methods We evaluated all patients with differentiated-type EGCs who were treated endoscopically and surgically in our hospital between January 2010 and October 2014. The clinicopathological features and long-term prognosis of MD-EGC were compared with those of PD-EGC. Results A total of 459 patients with 459 lesions were evaluated in this study; of them, 409 (89.1%) and 50 (10.9%) were classified into the PD and MD groups, respectively. Submucosal invasion was found in 96 (23.5%) patients of the PD group and in 33 (66.0%) patients of the MD group (p < 0.01). The rates of positive lymphatic and vascular invasion and ulceration were significantly higher in the MD group than in the PD group (p < 0.01). The proportion of patients with lymph node metastasis was also significantly higher in the MD group than in the PD group (5 (10%) vs 6 (1.5%), p < 0.01). The 5-year overall and EGC-specific survival rates in the PD group were 88.3 and 99.5%, respectively, while they were 94.0 and 98.0% in the MD group, respectively. Conclusions MD-EGC has more malignant potential than PD-EGC. However, the long-term prognosis of MD-EGC is good and is not significantly different from that of PD-EGC when treated appropriately.


Sign in / Sign up

Export Citation Format

Share Document